Roger Tell

Roger Tell, MD, PhD, currently serves as the Chief Medical Officer and Chief Executive Officer at Isofol Medical AB (publ) and is the Founder and CEO of Tell Oncology Consulting AB, providing expertise in drug development for pharmaceutical and biotech firms. As a member of the Board of Directors at Vivesto and a mentor with the Nordic Mentor Network For Entrepreneurship - NOME, Roger also contributes to One-carbon Therapeutics AB's Scientific Advisory Board. Previously, Roger held significant positions, including Assistant Professor at Karolinska Institutet, Vice President of Clinical Development at APREA Therapeutics AB, and International Clinical Project Director at Servier, among others. Roger's extensive clinical trial experience and research background in oncology are complemented by a PhD in Experimental Oncology obtained from Karolinska Institutet.